Merieux NutriSciences

Merieux NutriSciences

Merieux NutriSciences is the food testing and certification arm of the Institut Mérieux, a Lyon-based holding company controlled by the Mérieux family. The firm's origins trace back to 1967 when the Mérieux family leveraged existing expertise in microbiology and infectious disease to address food safety challenges. It has since expanded from initial microbiology and consulting services into chemistry, education, certification, research, labeling, and sensory analysis. The firm's core business involves laboratory testing (microbiology, composition, contaminants, allergens, GMOs), quality assurance consulting, supply chain auditing, and regulatory compliance services. It serves clients across food, beverage, nutraceutical, and pharmaceutical sectors. Merieux NutriSciences also offers software and data solutions, environmental monitoring, and corporate carbon footprinting. Its geographic footprint spans more than 30 countries, including all major regions: Europe (France, Germany, Italy, Spain, Poland, Netherlands, Belgium, Ireland, Portugal, Turkey, Russia), the Americas (US, Canada, Brazil, Chile, Colombia, Ecuador, Peru), Asia-Pacific (China, India, Japan, Thailand, Vietnam, Australia, Philippines, Singapore, Malaysia), and select markets in Africa and the Middle East (Morocco, South Africa, Saudi Arabia, Israel). With roughly 8,000 employees across over 100 accredited laboratories, the firm operates one of the largest private food-testing networks globally. Its headquarters are located in Chicago, Illinois, and its global parent Institut Mérieux is based in Lyon, France. The firm provides services through a network of local operating companies and joint ventures in each country. Recent operational developments include a May 2026 published guide on global labeling compliance for food exporters, and participation in GFSI 2026 conference. Unlike many contract testing laboratories, Merieux NutriSciences does not operate as a standalone entity but as part of a family-controlled public health ecosystem that includes vaccine manufacturer Sanofi Pasteur and diagnostics company bioMérieux. This allows the Institut Mérieux to cross-leverage scientific and regulatory expertise across human, animal, and food health. The firm's structure as a wholly owned subsidiary of Institut Mérieux, rather than a portfolio company owned by a family office investment vehicle, represents a distinct operating-company model rather than a typical family office.